SCHEMBL15118551

SCHEMBL15118551

CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)C(OC(=O)C(OC(=O)CCCCBr)C(NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)(C(OC(=O)c4ccccc4)C12)C3(C)C

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.80
TUBB4A P04350 4/20 0.80
TUBB P07437 4/20 0.80
TUBA3C P0DPH7 4/20 0.80
TUBA1B P68363 4/20 0.80
TUBA4A P68366 4/20 0.80
TUBB4B P68371 4/20 0.80
TUBB3 Q13509 4/20 0.80
TUBB2A Q13885 4/20 0.80
TUBB8 Q3ZCM7 4/20 0.80
TUBA3E Q6PEY2 4/20 0.80
TUBA1A Q71U36 4/20 0.80
TUBA1C Q9BQE3 4/20 0.80
TUBB6 Q9BUF5 4/20 0.80
TUBB2B Q9BVA1 4/20 0.80
TUBB1 Q9H4B7 4/20 0.80
ABCB11 O95342 2/20 0.80
NOD2 Q9HC29 2/20 0.80
MEN1 O00255 2/20 0.80
KMT2A Q03164 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13661869 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13661870 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13661876 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13661875 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL17620451 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL23642679 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13661877 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL126684 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL179687 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL127568 0.96 NPC1 (0.79) NPC1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150297738-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2015-10-22 US disclosed
US-20150297738-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2015-10-22 US disclosed
US-20140088298-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-27 US disclosed
US-20140088298-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-27 US disclosed
US-20140073779-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 US disclosed
US-20140073779-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 US disclosed
US-20130211060-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-08-15 US disclosed
US-20130211060-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-08-15 US disclosed
US-20130184455-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 US disclosed
US-20130184455-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088298-A9 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HACL2, HASPIN, LIPA NPC1 2629/4885TUBB4A 1604/4885TUBB 1505/4885
US-20130211060-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HACL2, HASPIN, LIPA NPC1 2629/4885TUBB4A 1604/4885TUBB 1505/4885
US-20150297738-A1 CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION HASPIN, HACL2, PCNA NPC1 1628/4885TUBB4A 1439/4885TUBB 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.